Long-term AAS use is associated with accelerated cardiovascular disease through multiple mechanisms including left ventricular hypertrophy, lipid dysregulation, endothelial dysfunction, and thrombotic risk from elevated hematocrit. Bloodwork alone cannot capture full cardiovascular risk — imaging is also needed.
HDL suppression and LDL/ApoB elevation creating atherogenic lipid profile
Elevated hematocrit increasing blood viscosity and thrombotic risk
Left ventricular hypertrophy from androgen-driven cardiac remodeling — not captured by bloodwork
Insulin resistance from AAS amplifying metabolic cardiovascular risk
GearCheck correlates your symptoms with your actual lab values and flags the specific markers driving the issue — not just a generic panel review.
Analyze My Bloodwork →GearCheck provides blood marker analysis and harm reduction education. Information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional.